首页> 外文期刊>RSC Advances >Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1
【24h】

Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1

机译:Apigenin通过抑制PI3K / AKT / GLUT1改善具有高果糖诱导的代谢干扰的大鼠血管损伤

获取原文
获取原文并翻译 | 示例
           

摘要

The abuse of fructose in daily diet may cause cardiovascular diseases that seriously threaten human health, and both safe and efficient solutions need to be developed. We investigated whether apigenin can prevent the harmful impact of excessive fructose on cardiovascular events. Based on the reduction of percentage of body fat and systolic pressure as well as the improvements in insulin resistance, lipid metabolism, and pathological injury to the thoracic aorta, we suggested that high levels of fructose cause vascular injury and metabolic disorders, which can be improved to some extent by using apigenin. Fundamentally, apigenin down-regulates levels of phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), and glucose transporter 1 (GLUT1), which increase with high concentrations of fructose. Moreover, the inflammation and asymmetric dimethylarginine (ADMA) levels increased in fructose group, but they decreased when the rats were fed with apigenin. The results suggest that PI3K/AKT/GLUT1 may have potential for alleviating cardiovascular injury, and apigenin can be an excellent candidate for supplements to ameliorate cardiovascular diseases related to high fructose consumption.
机译:在日常饮食中果糖的滥用可能会导致心血管疾病,严重威胁人类的健康,并需要开发既安全又有效的解决方案。我们研究了芹菜素是否能够防止过量果糖对心血管事件的有害影响。根据体内脂肪和收缩压百分比的降低,以及在胰岛素抵抗,脂质代谢,和病理损伤到胸主动脉的改进,我们建议,高水平的果糖的原因血管损伤和代谢障碍,这可以提高通过使用芹菜素一定程度。从根本上讲,芹菜素下调磷酸肌醇3-激酶(PI3K)的水平,蛋白激酶B(AKT),和葡萄糖转运1(GLUT1),其具有高浓度的果糖的增加。此外,炎症和不对称二甲基精氨酸(ADMA)的水平在果糖组升高,但是当大鼠用芹菜素喂他们降低。结果表明,PI3K / AKT / GLUT1可能有潜在的心血管减轻损伤和芹菜素可以成为一个优秀的候选人为补充,以改善与高果糖消费心血管疾病。

著录项

  • 来源
    《RSC Advances》 |2018年第43期|共7页
  • 作者单位

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Sch Pharmaceut Sci Minist Educ Key Lab Combinatorial Biosynth &

    Drug Discovery Wuhan 430071 Hubei Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号